News: Regeneus closes $3M private placement, page-10

I don't believe your statement is accurate littlecorn. Regeneus have had success treating dogs with their cancer vaccine.

"Regeneus had secured the exclusive rights for human applications of the cancer vaccine technology from Northern Sydney Local Health District following the success of the canine studies." Proactive Investors.

They are now preparing for the first in man safety trial using this technology, beginning Q1 2005. Regeneus are hoping that the success they've had in treating dogs with cancer is an indication that the personalized vaccine may work well in humans. The upcoming safety trial will shed light on this.

There are plenty of valuable products in the pipeline, with those stem cell cream thing representing one of those.

Kvax, Progenza, HiQCell, CryShot.

The stem cell cream has great potential as it has been shown to reduce redness and scarring from acne, big market.